Medicare now covers GLP-1 weight-loss drugs for $50 a month. Do you qualify?
Medicare’s new GLP-1 Bridge program (July 1, 2026 – December 31, 2027) gives eligible Medicare drug-plan members access to Wegovy, Zepbound, and Foundayo for a flat $50 monthly copay. The rules are strict and genuinely confusing — this guide explains them in plain English and links to the official requirements.
Check your eligibility in 2 minutes →
Coverage guidance updated October 5, 2026; see the linked CMS sources
Getting to $50 a month takes three steps
- Check your eligibility — 2 minutes, right here. Answer a few questions about your coverage, health, and BMI. Nothing is stored or sent anywhere. Start the check →
- Talk to your prescriber. Bring starting BMI and diagnosis records. The prescriber sends a prescription; the pharmacy submits a Bridge claim first, then the prescriber completes prior authorization. See the exact sequence.
- Fill your prescription for $50. Once approved, any participating pharmacy fills Wegovy, Zepbound (KwikPen), or Foundayo at a flat $50 a month — no deductible.
Three drugs, one price
Wegovy injections and tablets, Zepbound KwikPen and Foundayo tablets — $50 per approved 28-day or 30-day fill. Zepbound vials and single-dose pens are excluded.
Strict eligibility tiers
BMI at therapy initiation: 35+, or 30+ / 27+ with specific conditions. Type 2 diabetes, moderate-to-severe sleep apnea and noncirrhotic MASH with F2–F3 fibrosis use the Part D route.
Time-limited
The program ends December 31, 2027, and there is currently no announced plan to replace it. If you may qualify, the window to act is now.
Insurance and self-pay beyond the Bridge
Explore how to verify your plan’s GLP-1 coverage and how to compare drug, membership and refill costs. Medicare members can start with the Bridge versus Part D coverage routes.
Start here
- Eligibility checker — answer a few questions, see your likely path
- What is the Medicare GLP-1 Bridge? — the program explained in plain English
- Who qualifies — the three tiers, every qualifying condition, and the exclusions
- How to apply— there’s no form; your doctor applies for you
- Costs — the $50 mechanics, the Extra Help catch, and every comparison
- The covered drugs — Wegovy, Zepbound (KwikPen only), and Foundayo
- Practical guides — denials, pharmacy problems, caregivers, and edge cases
- Will the program be extended? — dated CMS guidance and planning considerations